Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
Phase 1
Terminated
- Conditions
- Peritoneal CancerSolid TumorPeritoneal Metastases
- Interventions
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Enlivex Therapeutics RDO Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT05581719
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱Hadassah Medical Center, Jerusalem, Israel
🇮🇱Sheba Medical Center, Ramat Gan, Israel
Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as Add-on to Standard of Care Chemotherapy for Treatment of Peritoneal Metastasis
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Enlivex Therapeutics RDO Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT05431907
- Locations
- 🇮🇱
The Chaim Sheba Medical Center, Ramat Gan, Israel
News
No news found